Oropharyngeal cancer: The role of chemotherapy

Current Treatment Options in Oncology

Volumn 4, Issue 1, 2003, Pages 3-13

  Adelstein, David J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Clin Oncol; Main Drug Interaction; Main Side Effect; Neck Cancer; Radiat Oncol Biol Phys

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CLINICAL TRIAL; HUMAN; OROPHARYNX TUMOR; REVIEW;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HUMANS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 0038048940     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-003-0027-6     Document Type: Article

References (32)

1. Adelstein DJ: Oropharyngeal cancer: the role of the medical oncologist in organ-function conservation. Am Soc Clin Oncol Educ Book 1999:544–550.
2. List MA, Stracks J, Colangelo L, et al.: How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 2000, 18:877–884.
3. Fu KK, Pajak TF, Trotti A, et al.: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003? Int J Radiat Oncol Biol Phys 2000, 48:7–16. DOI: 10.1016/S0360-3016(00)00663-5
4. Forastiere A, Koch W, Trotti A, et al.: Head and neck cancer? N Engl J Med 2001, 345:1890–1900. An excellent summary of recent advances in our understanding and treatment of this disease. DOI: 10.1056/NEJMra001375
5. Day GL, Blot WJ, Shore RE, et al.: Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol? J Natl Cancer Inst 1994, 86:131–137. DOI: 10.1093/jnci/86.2.131
6. Adelstein DJ, Tan EH, Lavertu P: Treatment of head and neck cancer: the role of chemotherapy? Crit Rev Oncol Hematol 1996, 24:97–116. DOI: 10.1016/1040-8428(96)00215-6
7. Forastiere AA, Metch B, Schuller DE, et al.: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group Study? J Clin Oncol 1992, 10:1245–1251.
8. Jacobs C, Lyman G, Velez-Garcia E, et al.: A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck? J Clin Oncol 1992, 10:257–263.
9. Murphy B, Li Y, Cella D, et al.: Phase III study comparing cisplatin & 5-fluorouracil versus cisplatin & paclitaxel in metastatic/recurrent head and neck cancer [abstract]? Proc Am Soc Clin Oncol 2001, 20:224a.
10. Adelstein DJ: Induction chemotherapy in head and neck cancer? Hematol Oncol Clin North Am 1999, 13:689–698. DOI: 10.1016/S0889-8588(05)70086-1
11. Pignon JP, Bourhis J, Domenge C, et al.: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data? Lancet 2000, 355:949–955. Results of the most comprehensive meta-analysis of chemotherapy in the definitive management of head and neck cancer.
12. Domenge C, Hill C, Lefebvre JL, et al.: Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma? Br J Cancer 2000, 83:1594–1598. The only oropharynx-specific trial of neoadjuvant chemotherapy to demonstrate a survival benefit. DOI: 10.1054/bjoc.2000.1512
13. Adelstein DJ: Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer? Curr Opin Oncol 1998, 10:213–218.
14. Lo TCM, Wiley AL, Ansfield FJ, et al.: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study? Am J Roentgenol 1976, 126:229–235.
15. Adelstein DJ, Adams GL, Li Y, et al.: A phase III comparison of standard radiation therapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): an Intergroup study [abstract]? Proc Am Soc Clin Oncol 2000, 19:411a.
16. Jeremic B, Shibamoto Y, Stanisavljevic B, et al.: Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial? Radiother Oncol 1997, 43:29–37. DOI: 10.1016/S0167-8140(97)00048-0
17. Adelstein DJ, Saxton JP, Lavertu P, et al.: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results? Head Neck 1997, 19:567–575. DOI: 10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5
18. Wendt TG, Grabenbauer GG, Rodel CM, et al.: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study? J Clin Oncol 1998, 16:1318–1324.
19. Brizel DM, Albers ME, Fisher SR, et al.: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer? N Engl J Med 1998, 338:1798–1804. DOI: 10.1056/NEJM199806183382503
20. Calais G, Alfonsi M, Bardet E, et al.: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma? J Natl Cancer Inst 1999, 91:2081–2086. An important study that helped establish concurrent chemoradiotherapy as a standard of care in the management of oropharyngeal cancer. DOI: 10.1093/jnci/91.24.2081
21. Staar S, Rudat V, Stuetzer H, et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: results of a multicentric randomized German trial in advanced head and neck cancer? Int J Radiat Oncol Biol Phys 2001, 50:1161–1171. DOI: 10.1016/S0360-3016(01)01544-9
22. Forastiere AA, Trotti A: Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer? J Natl Cancer Inst 1999, 91:2065–2066. DOI: 10.1093/jnci/91.24.2065
23. Vokes EE, Kies MS, Haraf DJ, et al.: Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer? J Clin Oncol 2000, 18:1652–1661.
24. Adelstein DJ, Saxton JP, Lavertu P, et al.: Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy? J Clin Oncol 2002, 20:1405–1410. DOI: 10.1200/JCO.20.5.1405
25. Bachaud JM, Cohen-Jonathan E, Alzieu C, et al.: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial? Int J Radiat Oncol Biol Phys 1996, 36:999–1004. DOI: 10.1016/S0360-3016(96)00430-0
26. Bernier J, Domenge C, Eshwege F, et al.: Chemoradiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: results of EORTC phase III trial 22931 [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:1. DOI: 10.1016/S0360-3016(01)01825-9
27. Cooper JS, Pajak TF, Forastiere AA, et al.: Postoperative concurrent radiochemotherapy in high risk SCCA of the head and neck: initial report of RTOG 9501/ Intergroup phase III trial [abstract]? Proc Am Soc Clin Oncol 2002, 21:226a.
28. Trotti A: Toxicity in head and neck cancer: a review of trends and issues? Int J Radiat Oncol Biol Phys 2000, 47:1–12. DOI: 10.1016/S0360-3016(99)00558-1
29. Arteaga CL: The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia? J Clin Oncol 2001, 19:32s-40s.
30. Clayman GL, Dreiling L: Local delivery for gene therapy? Curr Oncol Rep 1999, 1:138–143. DOI: 10.1007/s11912-999-0024-4
31. Brizel DM, Wasserman TH, Henke M, et al.: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer? J Clin Oncol 2000, 18:3339–3345.
32. LeVeque FG, Montgomery M, Potter D, et al.: A multicenter, randomized, double-blind placebocontrolled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients? J Clin Oncol 1993, 11:1124–1131.